Why GSK (GSK) is a Top Momentum Stock for the Long-Term
Yahoo Finance · 12 hours ago
Pfizer
Search results
- 45.15Add to watchlist-0.63 (-1.38%)At close:4:00 PM EDTThu. May 23, 202444.76 -0.39 (-0.86%)After hrs:7:42 PM EDTThu. May 23, 2024Nasdaq Real Time Price (USD) · Market closed
- Open45.75High45.77Low44.94
- Mkt Cap92.51BP/E (TTM)16.30Div & Yield1.50 & 3.33%
- Prev. Close45.7852 Wk. Low33.3352 Wk. High45.93
What analysts are sayingTop storiesRelated stocks
GSK is a global healthcare company that aims to improve and protect people's health. Learn about its vaccine initiative for adults, its diverse and inclusive culture, its latest results and news, and its career opportunities in the US.
- Careers
At GSK, we unite science, technology and talent to get ahead...
- Contact Us
GSK 2929 Walnut Street Ste. 1700 Philadelphia, PA 19104....
- Search Jobs
GSK Oncology is commited to the discovery & development of...
- Investors
Investors - Home | GSK US
- Company
At a glance. GSK has a significant footprint in the US...
- Global
We are a focused biopharma company with strong momentum and...
- Therapeutic Areas
Therapeutic Areas - Home | GSK US
- Haleon CMD to Demerger Archive
Emma Walmsley, Chief Executive Officer, GSK. 12:40-13:10 ....
- Location Selector
Location Selector - Home | GSK US
- Careers
GSK is the tenth largest pharmaceutical company and #294 on the 2022 Fortune Global 500, ranked behind other pharmaceutical companies China Resources, Sinopharm, Johnson & Johnson, Pfizer, Roche, AbbVie, Novartis, Bayer, and Merck Sharp & Dohme.
- GlaxoSmithKline (2000–2022)
- Public limited company
- Glaxo Wellcome, SmithKline Beecham
Find the latest GSK plc (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing.
GSK US is a global biopharmaceutical company with a significant presence in the US across R&D, manufacturing, and commercial functions. Learn about its portfolio, innovation, culture, diversity, and public health contributions in areas such as COVID, AMR, pricing, and vaccine hesitancy.
People also ask
What does GSK stand for?
Why is GSK a sustainable company?
Where is GSK located?
Who owns GSK powder?
May 3, 2023 · AREXVY is the first RSV vaccine for adults 60 and older, based on data from a phase III trial that showed 82.6% efficacy against lower respiratory tract disease. The vaccine is expected to launch in the US before the 2023/24 RSV season and is under review in Europe and other countries.
